During the past decade, Hospital "Dr. José Maria Cullen " conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 7 clinical trials were completed, i.e. on average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital "Dr. José Maria Cullen "" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "United Therapeutics" with 2 trials sponsored, "BHR Pharma, LLC" with 1 trials sponsored, "Cubist Pharmaceuticals LLC" with 1 trials sponsored and "Fresenius Kabi" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital "Dr. José Maria Cullen "" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hospital "Dr. José Maria Cullen "" are "Heart Failure" (2 trials), "Pulmonary Arterial Hypertension" (2 trials), "Brain Injuries" (1 trials), "Caloric Deficit" (1 trials) and "Complicated Intra-abdominal Infection" (1 trials). Many other conditions were trialed in "Hospital "Dr. José Maria Cullen "" in a lesser frequency.

Most popular intervention types in "Hospital "Dr. José Maria Cullen "" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Empagliflozin" (3 trials), "CXA-101/ tazobactam and metronidazole" (1 trials), "Folic Acid 4 mg" (1 trials) and "Linagliptin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital "Dr. José Maria Cullen "" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital "Dr. José Maria Cullen "". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Hospital "Dr. José Maria Cullen ", undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital "Dr. José Maria Cullen ", 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".